Charlene son rigby global genes
WebCharlene Son Rigby has spent her career building organizations at the intersection of data, technology, and life sciences. Charlene was previously Chief Business Officer at Fabric … WebOct 13, 2024 · The deal, which is expected to close by the end of year, will result in RARE-X CEO Charlene Son Rigby becoming CEO of the combined company. Meanwhile, Global Genes interim CEO Craig Martin will continue in that role to support the transition before officially joining the board of directors for the new company. The brands of both …
Charlene son rigby global genes
Did you know?
WebThrilled to announce that Global Genes and RARE-X are merging. Together we will be able to drive more impact for rare disease patients and advocates. ... Charlene Son Rigby on LinkedIn: #raredisease WebApr 7, 2024 · Global Genes and Orphan Disease Center at the University of Pennsylvania to hold 8th annual RARE Drug Development. ... development forward to a point where pharmaceutical and biotech companies are willing to in-license programs,” said Charlene Son Rigby, CEO of Global Genes. “We are working to demystify the therapy …
WebCharlene Son Rigby has spent her career building organizations at the intersection of data, technology, and life sciences. She currently serves … WebNov 13, 2024 · Charlene Son Rigby, President and Cofounder, STXBP1 Foundation. Charlene advocates for those affected by… STXBP1 encephalopathy. Charlene is …
WebCharlene Son Rigby’s Post Charlene Son Rigby reposted this Report this post Report Report. Back Submit. Michelle Campbell Patient-Focused Drug Development ... WebCharlene’s unplanned connection between her personal life and profession has helped push forward the search for a cure for her daughter and kids like her, and given her work …
WebJul 27, 2024 · RARE-X expands its leadership team to support the organization’s rapid growth. Aliso Viejo, CA —July 27, 2024 — RARE-X announced today that Charlene Son Rigby has been appointed CEO of …
WebJan 17, 2024 · “This challenge should demonstrate to researchers, drug developers, and patient advocates that people today are already using our data platform to unleash a new understanding of rare diseases to drive improvements in the diagnosis and treatments,” said Charlene Son Rigby, CEO of Global Genes. ali farzadWebThe RARE Health Equity Summit, hosted by Global Genes in partnership with the Rare Disease Diversity Coalition (RDDC) convenes all stakeholders in the rare disease community to identify collaborative efforts to address inequities in the care of patients with rare diseases, specifically focusing on reducing disparities, discrimination, and ... ali farzatWebJan 13, 2024 · “We are collaborating with CoRDS to expand the gathering of patient-reported outcomes from their health data,” said Charlene Son Rigby, CEO of Global Genes. “CoRDS shares the same commitment to patients as we do, and we are honored to collaborate with them to provide patients the ability to interconnect their data, making it … ali fathudinWebPart 3 of Global Genes’ Data DIY program focuses on generating interest among clinicians and researchers, growing and managing your scientific network, and exerting control over the destiny of your community’s research. ... Charlene Son-Rigby addresses Health Equity at V-BID Summit. Global Genes CEO Charlene Son Rigby spoke at the virtual V ... ali farzbodWebEd Narayan. “Reporting to Charlene for even a short period of time has been an invaluable experience. Her ability to successfully lead multiple teams (sales, marketing, client services) is a ... alifastWebFeb 27, 2024 · Global Genes CEO Talks Next-Generation Advocacy. Global Genes addresses challenges in the rare-disease community. CEO Charlene Son Rigby has … alifa storeWebMeet Wendy Erler, advocate and member of RARE-X Board of Directors! "Rare disease matters to me because we all need to be in this together - it is community… ali farzadi